NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy

Stock Information for Canalaska Uranium Ltd

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Canalaska Uranium Ltd

NeuroMetrix Reports Q1 2024 Business Highlights
NeuroMetrix Announces Steps Taken to Enhance Shareholder Value
NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia
Echo Lake Capital Issues Top Ten List of Reasons Why Shai Gozani, CEO of Neurometrix Inc., Should Be Fired
Echo Lake Capital Calls for the Liquidation of Neurometrix, Inc.
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call
NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value
Presenting on the Emerging Growth Conference 66 Day 1 on January 10 Register Now

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.